| Trial ID: | L3381 |
| Source ID: | NCT01353066
|
| Associated Drug: |
Intensive Medical Treatment
|
| Title: |
Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM)
|
| Acronym: |
EURDSS
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Atherosclerotic Cardiovascular Disease|Subclinical Disease and/or Syndrome
|
| Interventions: |
DRUG: Intensive Medical Treatment|OTHER: IMM+Roux-en-Y Gastric Bypass (RYGBP)
|
| Outcome Measures: |
Primary: Measurement of the progression carotid intima media thickness (CIMT) at 24 months after entry into the trial relative to baseline, 24 months |
|
| Sponsor/Collaborators: |
Sponsor: Hospital Clinic of Barcelona
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2|PHASE3
|
| Enrollment: |
240
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: |Intervention Model: |Masking: |Primary Purpose: TREATMENT
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2011-05-12
|
| Locations: |
Hospital Clínic de Barcelona, Barcelona, Catalunya, 08036, Spain
|
| URL: |
https://clinicaltrials.gov/show/NCT01353066
|
